Skip to content

Eye acupuncture and Ironing to reatment after a stroke shoulder hand syndrome (phlegm and blood stasis resistance winding) clinical trial

Eye acupuncture and Ironing to reatment after a stroke shoulder hand syndrome (phlegm and blood stasis resistance winding) clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15005902
Enrollment
Unknown
Registered
2014-12-07
Start date
2014-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder hand syndrome after stroke

Interventions

Control:Routine rehabilitation treatment
Teatment group 1:Routine rehabilitation treatment + Tong therapy
Treatment group 2:Routine rehabilitation therapy + Tong + eye needle

Sponsors

Liaoning university hospital of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Agreed to participate in this clinical trial and signed informed consent; 2. Aged 40-75 one full year of life; 3. In line with the diagnostic criteria of cerebral infarction patients; 4. In accordance with the traditional Chinese medicine after a stroke shoulder hand syndrome diagnostic criteria, phlegm and blood stasis resistance collaterals syndrome differentiation standards; 5. In line with the shoulder hand syndrome stage stage I of the standard, the onset of 2 week course of 3 months or less or less; 6. Imaging (CT or MRI) confirmed clinical classification for TACI or PACI OCSP; 7. VAS three points or more.

Exclusion criteria

Exclusion criteria: 1. (POCI), posterior circulation infarction patients with lacunar infarction (LACI). 2. Progress sex stroke, transient ischemic attack, cerebral hemorrhage and cerebral arteritis patients after cerebral infarction. 3. by a brain tumor, brain trauma, brain parasitic disease, rheumatic heart disease, coronary heart disease and other heart disease caused by atrial fibrillation cerebral embolism. 4. Acute vascular opening (such as thrombolysis, arteries, super early thrombus suction and stent angioplasty, etc.), such as treatment of the patients. 5. With bleeding tendency; Three months had severe bleeding. 6. With severe liver and kidney disease, hematopoietic system and metabolic diseases. 7. Severe and uncontrolled hypertension. 8. The law of patients with disability (blind, deaf, dumb, mental retardation, mental disorder and other reasons caused by physical disabilities affect the nerve function defect evaluators). 9. History of doubt or do have alcohol and drug abuse, or researchers think not suitable for the clinical subjects. 10. This test known or suspected drug allergies or allergic constitution. 11. Is in other clinical trials or any other drug clinical trials end does not exceed 3 months. 12. After a stroke shoulder pain patient has a periarthritis of shoulder and upper extremity fracture, peripheral nerve injury of upper limb function activity or cause pain diseases; 13. Except for acupuncture and moxibustion in the intervention and the Tong therapy also USES other therapies and the control group did not use this method.

Design outcomes

Primary

MeasureTime frame
VAS;VAS;GEPI;

Secondary

MeasureTime frame
Fugl - Meyer upper limb movement function score;ADL;NIHSS;TCM symptom score;TCM symptom score;

Countries

China

Contacts

Public ContactWang Pengqing
23318199@163.com+86 18102457199

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026